Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

about

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

Item

http://www.wikidata.org/entity/Q43266400

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@en

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@nl

type

Item

label

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@en

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@nl

prefLabel

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@en

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@nl

P1476

Methylnaltrexone and alvimopan: economic management of opioid-induced bowel dysfunction.

@en

P2093

Syed Z Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists

Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Oral naloxone reverses opioid-associated constipation.

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Methods for decreasing postoperative gut dysmotility.

A clinical pathway to accelerate recovery after colonic resection.

Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.

P304

153-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.4.2.153

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Kurz

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19807518

http://www.w3.org/2001/XMLSchema#string